Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / draft-fda-response-letter.docx
draft-fda-response-letter.docx
Parties
Harkness LLP
Associates LLP
M. Witherspoon
OF LETTER Penterra Pharmaceuticals Corp
Tavrenis Stern Consulting Group LLC
Ridgeline Health Analytics LLC
Keswick Bioanalytics Inc
March Communications LLC
Dates
January 5, 2024
January 12, 2024
October 12, 2023
October 16, 2023
October 11, 2019
January 15, 2024
November 8, 2023
November 1, 2023
December 31, 2022
March 15, 2021
Amounts
$814.6
$2.18
$1.85
$3.4
Obligations
The revised SOPs establish a formal escalation procedure under which any unresolved compliance dispute between Medical Affairs and other PRC functions must be escalated to the Chief Medical Officer and the General Counsel for joint resolution before a promotional material may be approved for dissemination